Clinical trial
A Randomized Trial on Efficacy and Safety of Ozanimod for the Treatment of COVID-19 Patients Requiring Oxygen Support - A Pilot Trial
NCT04405102 is registered in ClinicalTrials.gov with Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Trial on Efficacy and Safety of Ozanimod for the Treatment of COVID-19 Patients Requiring Oxygen Support - A Pilot Trial
- Lead sponsor
- Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- September 16, 2020
- Completion date
- May 12, 2022
- Enrollment
- 43 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.